Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the diabetes control and complications trial

被引:0
|
作者
Nathan, DM [1 ]
机构
[1] Massachusetts Gen Hosp, Diabet Univ Bulfinch 408, Boston, MA 02114 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To examine the differential effects of intensive and conventional diabetes therapy on weight gain and body composition in adults With type 1 diabetes. RESEARCH DESIGN AND METHODS - Between 1982 and 1989,1,246 adults (aged 18-39 years) in the Diabetes Control and Complications Trial were randomly assigned to either conventional therapy (1-2 injections of insulin per day) or intensive therapy (multiple daily injections or continuous subcutaneous infusion With frequent blood-glucose testing). Height and weight were measured at baseline and at annual Visits for an average of 6 years (range 3-9). Body Composition was assessed cross-sectionally with bioelectrical impedance analysis during 1992, at which time waist and hip circumferences were measured. RESULTS - Intensively treated patients gained an average of 4.75 kg more than their conventionally treated counterparts (P < 0.0001). This represented excess increases in BMI of 1.5 kg/m(2) among men and 1.8 kg/m(2) among women. Growth-curve analysis showed that weight gain was most rapid during the first year of therapy. Intensive therapy patients were also more likely to become overweight (BMI greater than or equal to 27.8 kg/m(2) for men, greater than or equal to 27.3 kg/m(2) for women) or experience major weight gain (BMI increased greater than or equal to5 kg/m(2)). Waist-to-hip ratios, however, did not differ between treatment groups, Major weight gain was associated with higher percentages of body fat and greater fat-free mass, but among patients without major weight gain, those receiving intensive therapy had greater fat-free mass with no difference in adiposity. CONCLUSIONS - Intensive therapy for type I diabetes produces substantial excess weight gain compared with conventional therapy. However, the additional weight appears to include lean tissue as well as fat.
引用
收藏
页码:1711 / 1721
页数:11
相关论文
共 50 条
  • [31] Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the diabetes control and complications trial
    Purnell, JQ
    Dev, RK
    Steffes, MW
    Cleary, PA
    Palmer, JP
    Hirsch, IB
    Hokanson, JE
    Brunzell, JD
    DIABETES, 2003, 52 (10) : 2623 - 2629
  • [32] The Effect of National Service on Metabolic Control, Weight Status and Incidence of Acute Diabetes Complications in Young Adults with Type 1 Diabetes
    Brener, Avivit
    Mel, Eran
    Shalitin, Shlomit
    Lazar, Liora
    de Vries, Liat
    Tenenbaum, Ariel
    Oron, Tal
    Farfel, Alon
    Phillip, Moshe
    Lebenthal, Yael
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2016, 18 (07): : 391 - 396
  • [33] History of the Diabetes Control and Complications Trial and Its Follow-up Epidemiology of Diabetes Interventions and Complications Study: Studies That Changed the Treatment of Type 1 Diabetes
    Nathan, David M.
    Lachin, John M.
    DIABETES CARE, 2024, 47 (09) : 1511 - 1517
  • [34] Intensive treatment of diabetes is associated with a reduced rate of peripheral arterial calcification in diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC)
    Carter, Rickey E.
    Cleary, Patricia A.
    Lackland, Daniel T.
    Yim, Eunsil
    Gilbert, Gregory E.
    Lopes-Virella, Maria
    Nathan, David M.
    Orchard, Trevor J.
    DIABETES, 2007, 56 : A32 - A32
  • [35] Intensive treatment of type 1 diabetes
    Hirsch, IB
    MEDICAL CLINICS OF NORTH AMERICA, 1998, 82 (04) : 689 - +
  • [36] The effect of intensive diabetes treatment on residual beta-cell function in the diabetes control and complications trial (DCCT).
    Steffes, M
    Tamborlane, W
    Becker, D
    Palmer, J
    Cleary, P
    DIABETES, 1996, 45 : 59 - 59
  • [38] The Effects of Intensive Diabetes Therapy on Nuclear Magnetic Resonance-determined Lipoprotein Subclass Profiles in Type 1 Diabetes in the Diabetes Control and Complications Trial (DCCT)
    Zhang, Ying
    Jenkins, Alicia J.
    Basu, Arpita
    Stoner, Julie A.
    Lopes-Virella, Maria F.
    Klein, Richard L.
    Lyons, Timothy J.
    DIABETES, 2014, 63 : A158 - A158
  • [39] Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes - "Double diabetes" in the Diabetes Control and Complications Trial
    Kilpatrick, Eric S.
    Rigby, Alan S.
    Atkin, Stephen L.
    DIABETES CARE, 2007, 30 (03) : 707 - 712
  • [40] Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study
    Purnell, Jonathan Q.
    Braffett, Barbara H.
    Zinman, Bernard
    Gubitosi-Klug, Rose A.
    Sivitz, William
    Bantle, John P.
    Ziegler, Georgia
    Cleary, Patricia A.
    Brunzell, John D.
    DIABETES CARE, 2017, 40 (12) : 1756 - 1762